⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9305969 | 1.00 | — | — | |
| SCHEMBL18071553 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL11250136 | 0.97 | — | — | |
| SCHEMBL6645101 | 0.92 | — | — | |
| SCHEMBL29637725 | 0.90 | NOS2 (0.41) | — | |
| SCHEMBL11252136 | 0.87 | NOS2 (0.45) | — | |
| SCHEMBL30075884 | 0.84 | NOS2 (0.38) | — | |
| SCHEMBL3370072 | 0.80 | — | — | |
| SCHEMBL4286200 | 0.77 | — | — | |
| SCHEMBL4286195 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 218 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111303178-B | Ovatodiolide derivative and salt thereof, preparation method and application thereof in preparing anti-cancer drugs | 合肥尚德药缘生物科技有限公司（CN） | 2023-01-13 | — | — | CN | claimed |
| CN-115364690-A | Copper-based material based on pH intelligent response, preparation method thereof and copper-based material composite film based on pH intelligent response | 湖南文理学院 | 2022-11-22 | — | — | CN | claimed |
| CN-115010719-A | Guaiane sesquiterpene dimer and derivative thereof and application of guaiane sesquiterpene dimer and derivative thereof in pharmacy | 中国科学院昆明植物研究所 | 2022-09-06 | — | — | CN | claimed |
| CN-114306329-A | Application of thiazolidine derivative in preparation of radionuclide contamination excretion promoting and protecting medicine | 中国医学科学院放射医学研究所 | 2022-04-12 | — | — | CN | claimed |
| EP-0385043-A1 | New derivatives of 4-substituted piperazines | FABRICA ESPANOLA DE PRODUCTOS QUIMICOS Y FARMACEUTICOS, S.A. (FAES) (ES) | 1990-09-05 | — | — | EP | claimed |
| JP-5194213-A | — | — | None | — | — | JP | disclosed |
| EP-4739395-A2 | BISPECIFIC POLYPEPTIDE MOLECULE | Enara Bio Limited (GB) | 2026-05-13 | — | — | EP | disclosed |
| US-20260091158-A1 | NON-PYROGENIC BACTERIAL CELLULOSE FOR BIOMEDICAL APPLICATIONS AND METHOD OF MANUFACTURE THEREOF | LABORATOIRES AXCELL (CA) | 2026-04-02 | — | — | US | disclosed |
| US-20260022131-A1 | 4-PHENYLPIPERIDINES, THEIR PREPARATION AND USE | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2026-01-22 | — | — | US | disclosed |
| US-12473302-B2 | 4-phenylpiperidines, their preparation and use | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2025-11-18 | — | — | US | disclosed |
| US-20250339551-A1 | AN ANTIBODY-DRUG CONJUGATE HAVING TWO OR MORE DIFFERENT FUNCTIONAL SMALL MOLECULES FOR ENHANCED TREATMENT OF REFRACTORY DISEASES | HANGZHOU SEEHE BIOTECHNOLOGY CO., LTD (CN) | 2025-11-06 | — | — | US | disclosed |
| US-20250289868-A1 | ANTI-VEGF PROTEIN COMPOSITIONS AND METHODS FOR PRODUCING THE SAME | REGENERON PHARMA (US) | 2025-09-18 | — | — | US | disclosed |
| EP-0145875-A2 | Gamma-aminobutyric acid transaminase inhibitors and processes for their preparation | MERRELL DOW PHARMACEUTICALS INC. (US) | 1985-06-26 | — | — | EP | disclosed |
| US-4520028-A | ANTIEPILEPTIC AGENTS; NERVOUS SYSTEM DISORDERS | MERRELL DOW PHARMACEUTICALS INC. (US) | 1985-05-28 | — | — | US | disclosed |
| US-4424225-A | ANTIULCER AGENTS | DR. KARL THOMAE GMBH (DE) | 1984-01-03 | — | — | US | disclosed |
| US-4410527-A | ANTIULCER AGENTS | DR. KARL THOMAE GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1983-10-18 | — | — | US | disclosed |
| US-4381301-A | Substituted tricyclic thieno compounds, their synthesis, their use, their compositions and their medicaments | BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) | 1983-04-26 | — | — | US | disclosed |
| US-4349552-A | TREATMENT OF CANCER | FUJISAWA PHARMACEUTICAL COMPANY, LTD. (JP) | 1982-09-14 | — | — | US | disclosed |
| EP-0010941-B1 | 5-FLUOROURACIL DERIVATIVES, PREPARATION THEREOF AND THEIR PHARMACEUTICAL COMPOSITIONS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1982-05-12 | — | — | EP | disclosed |
| EP-0010941-A1 | 5-Fluorouracil derivatives, preparation thereof and their pharmaceutical compositions | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1980-05-14 | — | — | EP | disclosed |